Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEED study of AD313 in OSA
NCT05101122Phase 2Completed
- Sponsor
- Apnimed, Inc.
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dronabinol in obstructive sleep apnea (OSA), sponsored by Apnimed, Inc.. Started Oct 2021; status: completed.
02
Drugs
dronabinol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05101122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05101122.